Evidence map›Paper›PMID 41945942›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2026

HPV Self-Sampling for Cervical Cancer Screening in Morocco: A Cross-Sectional Study.

Fatima Zahra Chellat, Nassiba Bahra, Youssef Chami Khazraji, Rachid Bekkali, Maria Bennani, Zineb Gaizi, Nabil Tachfouti, Samira El Fakir, Anasse Ben Abdallah, Mohammed El Mzibri and 1 more

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fatima Zahra ChellatInstitute of Cancer Research (IRC), Fez, Morocco.ORCID 0000-0003-1800-0546
Nassiba BahraLaboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine, Pharmacy and Dentistry, Sidi Mohammed Ben Abdellah University, 30000, Fez, Morocco.
Youssef Chami KhazrajiFoundation Lalla Salma Cancer prevention and treatment, 10000, Rabat, Morocco.
Rachid BekkaliFoundation Lalla Salma Cancer prevention and treatment, 10000, Rabat, Morocco.
Maria BennaniFoundation Lalla Salma Cancer prevention and treatment, 10000, Rabat, Morocco.
Zineb GaiziFoundation Lalla Salma Cancer prevention and treatment, 10000, Rabat, Morocco.
Nabil TachfoutiLaboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine, Pharmacy and Dentistry, Sidi Mohammed Ben Abdellah University, 30000, Fez, Morocco.
Samira El FakirLaboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine, Pharmacy and Dentistry, Sidi Mohammed Ben Abdellah University, 30000, Fez, Morocco.
Anasse Ben AbdallahLaboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine, Pharmacy and Dentistry, Sidi Mohammed Ben Abdellah University, 30000, Fez, Morocco.
Mohammed El MzibriNational Centre for Nuclear Energy, Science and Technology, Rabat, Morocco.ORCID 0000-0002-3148-1527
Mohamed BerrahoInstitute of Cancer Research (IRC), Fez, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMorocco is currently planning to introduce HPV testing as the primary screening method in routine cervical cancer screening. Accordingly, HPV self-sampling offers a potential solution to increase participation rates, particularly in underserved regions. Therefore, this study was designed to assess the feasibility and acceptability of HPV self-sampling using the GeneXpert assay as an alternative to clinician-administered screenings in Morocco.

methodsA cross-sectional study was conducted among 997 women aged 30 or 40 years from four Moroccan provinces. Participants were offered the choice of clinician-collected sampling, supervised self-sampling, or unsupervised self-sampling. Socioeconomic and clinical data were collected using structured questionnaires, and HPV detection and genotyping were performed using the GeneXpert HPV assay.

resultsOverall, 13% of participants opted for self-sampling, including 4.8% who chose unsupervised, and 8.2% supervised self-sampling. Women living in urban areas, younger participants (30 years old), and those with higher education and income levels were more likely to select self-sampling. Satisfaction was high: 92.2% found the procedure easy to perform, all participants reported comfort using the cytobrush, and all indicated willingness to recommend the test to relatives or friends. Additionally, the diagnostic performance of high-risk HPV (hrHPV) testing was comparable between self-collected and clinician-collected samples, demonstrating no effect of sampling method on HPV detection.

conclusionHPV self-sampling is feasible and highly acceptable among Moroccan women. However, the low uptake, particularly in rural settings, highlights the need for targeted education and awareness efforts. Integrating self-sampling into national screening programs may improve participation and contribute to reducing cervical cancer incidence in Morocco.

Indexed as

Early Detection of CancerHuman Papillomavirus VirusesPapillomaviridaePapillomavirus InfectionsSelf CareSpecimen HandlingUterine Cervical NeoplasmsAdultCross-Sectional StudiesFemaleFollow-Up StudiesHumansMass ScreeningMoroccoPrognosisVaginal SmearsHPV testingHuman papillomavirus (HPV)Moroccoself-sampling

Identifiers

PMID41945942
PMCPMC13609204

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.